Clin2
NCT07683598Possibly a fitNot yet recruiting

DLBS1033 for diabetic nerve pain: a study

Diabetic Neuropathy

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This trial tests if adding DLBS1033 to standard treatment can help people with diabetic neuropathy, a nerve condition causing pain or numbness from diabetes. It aims to see if it improves nerve symptoms and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have diabetes-related nerve damage with symptoms like pain, numbness, or tingling in your hands or feet.
  • You are 18 years old or older.
  • You are willing to take part and sign a consent form.
  • You can fill out a quality-of-life questionnaire, with help if needed.
  • You do not have other causes of nerve damage, like heavy alcohol use or certain medications.
  • You are not pregnant or breastfeeding.
  • You do not have an active infection or inflammatory condition like a fever or autoimmune disease.
  • You are not allergic to the study medication, DLBS1033.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07475065Not yet recruiting· Phase 2/Phase 3
Oral DLBS1033 for diabetic nerve pain

This study tests whether a daily oral supplement called DLBS1033 can help relieve nerve pain and other symptoms of diabetic polyneuropathy. It may be a good option if you have stable blood sugar and no other major health issues.

Surakarta, Central Java
NCT07028528Recruiting· Phase 2
Study of Levagen+ for diabetic nerve pain

This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.

Fortitude Valley, Queensland
NCT07285018Recruiting· Phase 2
Study of a new drug for diabetic nerve pain in legs

This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.

Birmingham, Alabama
NCT07159243Not yet recruiting· Phase 2
Testing a new drug for diabetic nerve pain

This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.

NCT07183761Recruiting· Phase 2
Stem cell therapy for diabetic nerve pain

This study tests whether umbilical cord stem cells can help people with diabetic nerve damage in their legs who haven't gotten enough relief from standard treatments. It aims to improve symptoms like numbness, pain, and tingling.

Chongqing, Chongqing Municipality
NCT07518433Not yet recruiting
Blood tests to understand diabetic nerve pain

This study analyzes blood samples from people with diabetes to understand what causes nerve pain and damage in the legs and feet. Researchers will compare blood from three groups: people with diabetic nerve pain, people with diabetes but no nerve problems, and healthy volunteers without diabetes.

Hangzhou, Zhejiang

Hear when a new Diabetic Neuropathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.